Private equity
Click here to find out more
What is it like doing a deal in lockdown?
2 November 2020
In-depth analysis
by Suzy Davis
Interface - The latest in life sciences
Click here to find out more
Private equity investment in life sciences sector
Exploring some of the potential benefits and challenges for life sciences companies considering PE investment.
30 July 2020
IN-DEPTH ANALYSIS
by multiple authors
4 of 6 Insights
Coronavirus
Click here to find out more
COVID-19: Private equity investors and investor directors – dealing with distress
24 March 2020
IN-DEPTH ANALYSIS
Private equity
Click here to find out more
Owning artworks – the chimera of possessions?
11 March 2020
QUICK READ
Life sciences & healthcare
Click here to find out more
IP, divestments, fragmentation and the future: M&A in life sciences
30 September 2019
Briefing
by Emma Danks
Tax
Click here to find out more
Autumn Budget 2018: additional requirements introduced and holding period extended for Entrepreneurs' Relief
31 October 2018
Private equity
Click here to find out more
Corporate governance reforms and the impact for portfolio companies in 2018
30 January 2018
QUICK READ